According to Market Research Future®, the Regadenoson Market Trends indicate that the market was valued at USD 500 million in 2024 and is expected to reach USD 500 million in 2025 before expanding to USD 1.5 billion by 2035, registering a CAGR of 10.6% during the forecast period. Increasing adoption of myocardial perfusion imaging procedures, growing demand for cardiovascular diagnostic...